Multifactorial Risk Control Lowers Liver Disease Burden in Type 2 Diabetes, Study Shows
China: Patients withtype 2 diabetes (T2D)face a substantially higher risk of developing severemetabolic dysfunction-associated steatotic liver disease (MASLD)and major adverse liver outcomes (MALO). However, this risk can be significantly reduced when multiplelifestyleand clinical factors are simultaneously controlled, a large prospective cohort study published inBMJ Open Diabetes Research & Carehas revealed.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!